Dr. Barry Behr<\/a>, fulfilling the role of Chief Technology Officer (CTO). Dr. Behr is a Stanford University Professor Emeritus, where he served as Director of the IVF Laboratory and Professor of Obstetrics and Gynecology. A leading expert in the IVF field, his embryo research has directly led to improved implantation and pregnancy rates.<\/p>\n“With our cutting-edge technology for improved WOI assessment and gamete selection,” said Dr. Behr, “we foresee a not-too-distant future in which a perfect embryo can be reliably achieved in the first IVF cycle. That means one sperm, one egg, and one implantation to deliver a healthy baby.”<\/p>\n
Considering MIRA\u00ae’s promising early success and other tests nearing the prototype phase, Inti Labs believes IVF will become increasingly reliable and affordable to women everywhere, as we work towards a future where infertility is no longer an insurmountable obstacle.<\/p>\n
—<\/p>\n
Inti Labs will be attending the 2022 ASRM Scientific Congress & Expo Oct 24-26 in Anaheim, CA, and invites you to visit their booth (#1433).<\/p>\n
Contact Information:<\/b><\/strong>
\nJesse Prent
\nMarketing Director
\njesse@intilabs.com<\/a>
\n(438) 405-1050<\/p>\nTiffany Wang
\nGlobal Business Development Director
\ntiffany@intilabs.com<\/a><\/p>\nRelated Images<\/b><\/strong><\/p>\n <\/a><\/p>\n Image 1: Inti Labs logo<\/b><\/strong> <\/a><\/p>\nThis content was issued through the press release distribution service at Newswire.com<\/a>.<\/p>\n